A simple LC-MS/MS method for determination of magnolol in rat blood and its application in a pharmacokinetic study

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 2, 2012, Pages 83-87

  Li, H ^a   Wen, X S ^a   Di, W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

LC MS MS; magnolol; pharmacokinetics

Indexed keywords

ACETONITRILE; MAGNOLOL; METHANOL; ANTINEOPLASTIC AGENT; BIPHENYL DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; LIGNAN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROSPRAY; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; QUADRUPOLE MASS SPECTROMETRY; RAT; TANDEM MASS SPECTROMETRY; ANIMAL; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY DIAGNOSIS; LIMIT OF DETECTION; QUALITY CONTROL; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; STANDARD;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FREEZING; INDICATORS AND REAGENTS; LIGNANS; LIMIT OF DETECTION; MALE; QUALITY CONTROL; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84859897155     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1295485     Document Type: Article

References (13)

1. Li M H, Kothandan G, Cho S J et al. Magnolol Inhibits LPS-induced NF-κB/Rel Activation by Blocking p38 Kinase in Murine Macrophages. Korean J Physiol Pharmacol: 2010; 14 353 358
2. Yang S E, Hsieh M T, Tsai T H et al. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochemical Pharmacology: 2002; 63 1641 1651
3. Yang S E, Hsieh M T, Tsai T H et al. Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br J Pharmacol: 2003; 138 193 201
4. Seo J U, Kim M H, Kim H M et al. Anticancer potential of magnolol for lung cancer treatment. Arch Pharm Res: 2011; 34 625 633
5. Hwang E S, Park K K. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells. Biosci Biotechnol Biochem: 2010; 74 961 967
6. Lin S Y, Chang Y T, Liu J D et al. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol Carcinogen: 2001; 32 73 83
7. Lin S Y, Liu J D, Chang H C et al. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem: 2002; 84 532 544
8. Ikeda K, Nagase H. Magnolol has the ability to induce apoptosis in tumor cells. Biol Pharm Bull: 2002; 25 1546 1549 (Pubitemid 39663667)
9. Lee J, Jung E, Park J et al. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med: 2005; 71 338 343 (Pubitemid 40676458)
10. Kotani A, Kojima S, Hakamata H et al. Determination of honokiol and magnolol by micro HPLC with electrochemical detection and its application to the distribution analysis in branches and leaves of Magnolia obovata. Chem Pharm Bull: 2005; 53 319 322 (Pubitemid 40879905)
11. Wu Y T, Lin L C, Tsai T H. Simultaneous determination of honokiol and magnolol in Magnolia officinalis by liquid chromatography with tandem mass spectrometric detection. Biomed Chromatogr: 2006; 20 1076 1081
12. Lin S P, Tsai S Y, Lee Chao P D et al. Pharmacokinetics, Bioavailability, and Tissue Distribution of Magnolol Following Single and Repeated Dosing of Magnolol to Rats. Planta Med: 2011; Jun 1 [Epub ahead of print]
13. US FDA Guidance for Industry-Bioanalytical Method Validation. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. May: 2001; Available from: http://www/fda.gov/cder/guidance/index.htm.